LYC-30937

· Lycera Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LYC-30937, covering 2016-12-14 to 2016-12-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis [Phase 1]